With Mirati hot on its tail, Amgen’s KRAS-targeting Lumakras combo heads into late-stage colorectal cancer testing

With Mirati hot on its tail, Amgen’s KRAS-targeting Lumakras combo heads into late-stage colorectal cancer testing
nhigginsdunn
Thu, 09/16/2021 – 11:39